When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Which cardiovascular drugs may help lower dementia risk? - AOL

   www.aol.com/cardiovascular-drugs-may-help-lower...

   Researchers found that taking certain commonly prescribed drugs for 5 years or more was associated with a decreased risk of dementia. These drugs included: antihypertensives — drugs that treat ...

3. Diuretic pill could be potential treatment for Alzheimer’s ...

   www.aol.com/diuretic-pill-could-potential...

   A commonly prescribed water pill could potentially be repurposed as a possible Alzheimer’s disease treatment for some people who are genetically at risk, scientists have said. ... The analysis ...

4. Bumetanide - Wikipedia

   en.wikipedia.org/wiki/Bumetanide

   Bumetanide is a loop diuretic and works by decreasing the reabsorption of sodium by the kidneys. The main difference between bumetanide and furosemide is in their bioavailability and potency. About 60% of furosemide is absorbed in the intestine, and there are substantial inter- and intraindividual differences in bioavailability (range 10-90%).

5. Prevention of dementia - Wikipedia

   en.wikipedia.org/wiki/Prevention_of_dementia

   The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. [1] [2] Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) [3] which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory ...

6. Two Alzheimer’s drugs help patients live independently at ...

   www.aol.com/two-alzheimer-drugs-help-patients...

   Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

7. Loop diuretic - Wikipedia

   en.wikipedia.org/wiki/Loop_diuretic

   However, for torsemide and bumetanide, their oral bioavailability is consistently higher than 90%. Torsemide has a longer half life in heart failure patients (6 hours) than furosemide (2.7 hours). A 40 mg dose of furosemide is clinically equivalent to a 20 mg dose of torsemide and to a 1 mg dose of bumetanide. [6]